We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| CME Group Inc | NASDAQ:CME | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.36 | 0.18% | 197.37 | 197.02 | 199.60 | 199.55 | 197.08 | 198.29 | 1,965,769 | 21:00:10 |
From Jul 2019 to Jul 2024
By Michael Dabaie
CME Group (CME) said Friday it received clearance from the U.S. Justice Department's antitrust division for its proposed acquisition of NEX Group PLC (NXG.LN)
Security and commodity exchange company CME in March agreed to buy U.K. financial-technology company NEX for about $5.4 billion.
CME said it has also received relevant regulatory approvals from the Financial Conduct Authority and regulators in the U.S., Germany, Italy and Sweden, and have made requisite pre-notifications in Hong Kong. The deal remains subject to closing conditions, including U.K. Competition and Markets Authority clearance and the sanctioning of the transaction by the U.K. Court. The deal is still expected to close by the end of the year.
CME shares were recently down about 1% to $174.40. The stock is up about 27% in the last year.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
October 12, 2018 14:49 ET (18:49 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year CME Chart |
1 Month CME Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
